CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- 4 Open-market sale Director sold 2,000 shares at $241.00 ($482,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 6,000 shares at $203.33 ($1,219,980)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K/A Report 10-K/A
- 4 Planned sale Director sold 6,000 shares at an average $190.50 ($1,143,010)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Director gave up 15,114 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Financial Officer gave up 2,615 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, Technical Operations gave up 1,394 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Commercial Officer gave up 2,503 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Global Head of R&D & CMO gave up 6,209 shares (to pay taxes)
- 4 Open-market sale SVP, Chief Accounting Officer sold 1,287 shares at $182.94 ($235,444)
- 4 Shares withheld for taxes President & CEO gave up 7,065 shares (to pay taxes)
- 4 Shares withheld for taxes EVP & Chief Legal Officer gave up 5,000 shares (to pay taxes)
Page 6 of 110 · 2,194 filings